BOA2019 - Central Nervous System

There has been a recent flurry of practice-changing options for managing brain and spine metastases as a result of refinements in pathological classification of tumors, better systemic management options, improved imaging permitting precise localization of pathology and avoidance structures within the brain and spine, and better radiotherapy technology. Optimal management of individual patients requires the integration of knowledge across a range of disciplines and an understanding of situations for which clinical trials have not yet provided definitive answers.

 

Target Audience

The meeting is designed to meet the interests of radiation oncologists and residents.

Learning Objectives

  • Select radiation approaches for patients with painful (but stable) spine metastases and brain metastases
  • Identify patients with low-grade gliomas who should not receive PCV chemotherapy after partial brain irradiation
  • Counsel patients and other healthcare professionals about the expected outcomes from salvage radiation with concomitant bevacizumab for recurrent glioblastoma
Course summary
Available credit: 
  • 1.00 SA-CME

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

    The American Society for Radiation Oncology (ASTRO) designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.00 self-assessment credits.

  • 1.25 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.
Course opens: 
10/30/2019
Course expires: 
11/25/2019
Cost:
$0.00
Rating: 
0

The following persons served as faculty for this activity:

Jonathan Knisely, MD, FASTRO is employed at Weill Cornell Medicine and has no other disclosures.

Additionally, the Education and CME/MOC Committee had control over the content of this activity.

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification. 

Available Credit

  • 1.00 SA-CME

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

    The American Society for Radiation Oncology (ASTRO) designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.00 self-assessment credits.

  • 1.25 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.

Accreditation Period

Course opens: 
10/30/2019
Course expires: 
11/25/2019

Price

Cost:
$0.00
Please login or register to take this course.

Policies: 

  • No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session.
  • No credits will be granted and no refunds, exchanges or transfers will be given to those who do not pass.
  • ASTRO staff cannot make modifications to your submitted materials.
     

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.